FdaApplication

NDA 050786

Back to search

Identifiers

Properties

PropertyValue
applicant_nameLABORATOIRES JUVISE PHARMACEUTICALS
application_typeNDA
approval_date2006-09-28

Products (1)

ProductActive ingredientStrengthDosage form
PYLERABISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE140MG;125MG;125MGCAPSULE;ORAL

1 product